Negative SPR rules out direct binding to folded recombinant ID1, but does not exclude covalent, allosteric, or cellular-context-dependent interactions. Suppression of all four ID proteins within 24 hours is most consistent with a shared post-translational node. The strongest literature precedent is USP1, the deubiquitinase that stabilizes ID1; USP1 inhibition (e.g., pimozide, carbodoxime analogs) triggers proteasomal ID1 degradation without any direct ligandβID1 engagement (). A transcriptional route remains plausible: ID1 is rapidly induced by upstream signals such as TGF-Ξ²1 in tubular epithelial cells (), and STINGβID1 axis data show ID1 is downstream of stress pathways (). However, a single upstream regulator that simultaneously suppresses ID1, ID2, ID3, and ID4 within 24h is less parsimonious than a shared degradation machinery.
1. Paired mRNA/protein time course (0, 2, 6, 12, 24h X6632): RT-qPCR for ID1β4 + Western blot. Early protein loss with intact mRNA β post-transcriptional. Coordinated mRNA + protein loss β transcriptional.
2. MG132/lactacystin rescue: proteasome inhibitor added 4h before X6632. Full rescue of ID protein levels confirms degradation mechanism.
3. Cycloheximide chase: X6632 should shorten ID1β4 protein half-life in the degradation model, with no effect in the transcriptional model.
4. USP1 activity assay + ubiquitination pull-down: assesses whether X6632 inhibits USP1 or promotes ID ubiquitination, directly testing the mechanistic precedent ().
5. ID promoterβluciferase and BMP/Smad reporter: unaffected promoter activity despite protein loss further supports post-transcriptional action.
Confidence: moderate β inference based on the known USP1βID1 degradation axis, not on direct X6632 data. Falsification of the degradation hypothesis: ID1β4 protein remains suppressed in the presence of MG132 and mRNA falls concurrently.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.